Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
about
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axisThe role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.Kisspeptin modulates sexual and emotional brain processing in humans.Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteers.Neuroendocrine causes of amenorrhea--an update.Hyperprolactinemia and infertility: new insightsEP24.15 as a Potential Regulator of Kisspeptin Within the Neuroendocrine Hypothalamus.Giant prolactinomas: the therapeutic approach.Endocrine autoimmune diseases and female infertility.Prolactinomas, cabergoline, and pregnancy.New insights in prolactin: pathological implications.An updated view of hypothalamic-vascular-pituitary unit function and plasticity.Interactions between prolactin and kisspeptin to control reproduction.Impact of Triclosan on Female Reproduction through Reducing Thyroid Hormones to Suppress Hypothalamic Kisspeptin Neurons in Mice.Plasma kisspeptin levels in lactational amenorrhea.Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea.
P2860
Q28087609-79233782-AFB1-4B5C-93C9-E6AAE78B7D27Q30251689-4D660854-FC51-4159-A8C5-2ECEC900ABB0Q30836691-166B2F09-FD6E-4ADB-81FA-00A4A7342252Q33953607-7A5D7D8C-6613-4FEC-9A7D-D9C70843522AQ35096850-A298C503-6205-485C-89D7-DE46094A2CF0Q36290344-7D21AD22-FF2E-4701-B258-F38B0FFF4628Q36521152-01D5C094-724D-4D70-9E98-DFE0FF3F2464Q38105620-43FB93CD-D3A8-4229-8047-00633487599CQ38159892-BBDD637D-9A44-4CCB-964F-6406A729BBFCQ38225350-119061B1-CA4A-48DF-9305-34B827A70277Q38381546-E012CD19-24F8-40B1-96DE-6E94A3C04DB3Q38785172-54C632E5-9630-41DD-A4DF-6CF50CA4F8B5Q39024370-B980772D-99EA-4D6E-B43F-75D2BADB722DQ49438807-1FB1389A-65EE-414A-B42A-7D7E88DBC3C9Q52095665-E62D99B1-12AE-4E53-AAA4-1C73F3431B2EQ55022868-8180EC55-D511-4286-AF7B-67CDEAB89045
P2860
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
@ast
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
@en
type
label
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
@ast
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
@en
prefLabel
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
@ast
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
@en
P2093
P2860
P50
P356
P1476
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration
@en
P2093
Alain Caraty
Charlotte Sonigo
Fabian-Jesus Simony-Conesa
Justine Bouilly
Nadine Binart
Nadège Carré
Virginie Tolle
P2860
P304
P356
10.1172/JCI63937
P407
P577
2012-09-24T00:00:00Z